Marcia Brackman

发表

A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy

M. Hofman, A. Catafau, M. Seltzer, 2023, Journal of Nuclear Medicine.

Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial).

R. Garje, Sarah L Atzen, Andrew J. Armstrong, 2024, Radiology.